Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Anxiety Disorders

Clinical Trial Details

Overview

Research Study Summary

A Phase 3 clinical study for patients with Anxiety Disorder

Research Study Title

Double Blind, Randomized Study, Controlled by Valeriana Officinalis, of Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Patients With Mild and Moderate Anxiety

Purpose

Phase III, multicentric, double blind, randomized study, controlled by Valeriana officinalis for evaluating the efficacy of association of Passiflora incarnata L; Crataegus Oxyacantha L and Salix alba L. on mild and moderate anxiety. The treatment period will last 6 weeks and be followed by a post treatment visit.

Hamilton anxiety scale will be used to assess anxiety.

To Learn more
Phase

3

Gender

Both Male and Female

Age

18 to 65 Years

Overall Status

Recruiting

Lead Sponsor

Marjan Industria e Comercio ltda

Duration

39 Months

Facility Type

N/A

Eligibility

Both Male and Female ages 18 Years to 65 Years

Inclusion Criteria:

  • generalized anxiety disorder

  • HAM-A scale < 17 and > 30

Exclusion Criteria:

  • hypersensibility to any component

  • patients with depression, schizophrenia ou suicidal ideas

  • pregnant ou lactating

  • heart, liver, lung or kidney important condition

  • use of digitalis, AAS, anticoagulants agents, drugs with sedative or antidepressant action

  • psychotherapy

  • drug or alcohol dependence

  • gastrointestinal ulcer history

  • hyperthyroidism

  • neoplasia

  • coagulation disorders

Site Locations (2)

Country State City Zip Facility and Contact
Brazil Ceará Fortaleza 60430-270 Unidade de Farmacologia Clínica - UNIFAC
Jonaina C Oliveira
55-85-32232600
jonaina.gu@ig.com.br

Maria Elizabete A Moraes, MD
Principal Investigator
Brazil Sao Paulo 04024-002 SPDM - Associação Paulista para o Desenvolvimento da Medicina - Hospital São Paulo
Fernanda M Gazoni, MD
55-11-9658-0467
fmgazoni@hotmail.com

Antonio C Lopes, Phd
Principal Investigator

NCT ID: NCT00794456

Date Last Changed: May 23, 2012

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Some study summaries have been edited for clarity purposes to make them easier to understand. View more study details here.